Dhampur Bio Organics Limited has informed the Exchange regarding 'Certificate from Chief Financial Officer confirming the utilisation of proceeds from Commercial Paper'.
DBOL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dhampur Bio Organics Limited has submitted a certificate from its Chief Financial Officer, Nalin Kumar Gupta, confirming that proceeds raised through Commercial Paper during the quarter ended June 30, 2025 were used for the purposes originally disclosed. This filing is made in line with the SEBI circular dated April 13, 2022, which requires listed companies issuing Commercial Papers to certify proper use of funds. The certificate confirms that other listing conditions under the same SEBI circular were also met. The letter is signed by Company Secretary Ashu Rawat and submitted to both BSE and NSE.
This is a routine regulatory compliance filing and does not signal any operational or financial change. It reassures investors that the company's short-term borrowing via Commercial Papers is being used appropriately, but it is unlikely to move the stock price.